Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of carcinomas that remain difficult to treat withconventional cytotoxic regimens. The 2014 American Society of Clinical Oncology (ASCO) Gastrointestinal CancersSymposium brought us new insights into the management of gastroenteropancreatic neuroendocrine tumors. The focus ofthis review will serve to highlight specific Abstracts (#268 and #273) that help shed light on a novel, targeted means oftreating gastroenteropancreatic neuroendocrine tumors.
